drugset / Trial / NCT00808626

Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis

NCT00808626 ↗

Phase 1/2 Withdrawn Temple University
NaSingle-groupOpen-labelDiagnostic

Summary

99mTc-rBitistatin is a radiolabeled polypeptide which is designed to stick to blood clots so that the blood clots can be detected by imaging. The purpose of this trial is to evaluate in patients the safety of 99mTc-rBitistatin and its ability to locate blood clots in the arms and legs.

Timeline

Start
2008-12
Primary completion
2017-03
Completion
2017-03

Outcome

Outcome not reported

Stopped (Business): “Lack of funding to complete trial. A lead member of research team retired.”

Drugs

EvaluationDrugModalityDoseRoute
Subject 99mTc-rBitistatin Unknown 0.1 ug/kg Intravenous
Subject 99mTc-rBitistatin Unknown 370 mbq Intravenous